fda
35 records
FDA Drug Recall: Norepinephrine 4 mg per 250 mL (16 mcg per mL) in 0.9% Sodium Chloride, 250 mL S
2023-07-26
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: Sodium Bicarbonate in 5% Dextrose Injection, 150 mEq per 1,000 mL (12.6 mg per m
2023-07-26
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: Norepinephrine 16 mg per 250 mL (64 mcg per mL) in 0.9% Sodium Chloride, 250 mL
2023-07-26
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: Norepinephrine 8 mg per 250 mL (32 mcg per mL) in 0.9% Sodium Chloride, 250 mL S
2023-07-26
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: Norepinephrine 32 mg per 250 mL (128 mcg per mL) in 0.9% Sodium Chloride, 250 mL
2023-07-26
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: fentaNYL Citrate in 0.9% Sodium Chloride, 2.5 mg per 250 mL, (10 mcg per mL) IV
2022-08-17
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: FentaNYL Citrate in 0.9% Sodium Chloride 1 mg per 100 mL (10 mcg per mL) IV bags
2022-08-17
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: MORPHINE SULFATE, in 0.9% Sodium Chloride Injection, 50 mg per 50 mL, (1 mg per
2022-01-05
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: NOREPINEPHRINE, 16 mg per 250 mL, (64 mcg per mL) in 5% Dextrose Injection, Rx o
2022-01-05
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: NOREPINEPHRINE, 16 mg per 250 mL, (64 mcg per mL) in 0.9% Sodium Chloride Inject
2022-01-05
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: NOREPINEPHRINE, 8 mg per 250 mL, (32 mcg per mL) in 0.9% Sodium Chloride Injecti
2022-01-05
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: Fentanyl Citrate, in 0.9% Sodium Chloride Injection, 1 mg per 100 mL, (10 mcg pe
2022-01-05
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: PHENYLephrine HCl, 40 mg per 250 mL, (160 mcg per mL) in 0.9% Sodium Chloride In
2022-01-05
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: Succinylcholine Chloride Injection, 200 mg per 10 mL (20 mg per mL), 1,000 mL, R
2022-01-05
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: Sodium Bicarbonate in 5% Dextrose Injection, 150 mEq per 1000 mL (12.6 mg per mL
2022-01-05
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: Midazolam in 0.9% Sodium Chloride Injection, 50 mg per 50 mL (1 mg per mL), Rx o
2022-01-05
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: Morphine Sulfate in 5% Dextrose Injection, 100 mg per 100 mL (1 mg per mL), Rx o
2022-01-05
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: dilTIAZem HCl 125 mg per 125 mL (1 mg per mL) in 0.7% Sodium Chloride Injection,
2022-01-05
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: Midazolam in 0.9% Sodium Chloride Injection, 100 mg per 100 mL (1 mg per mL), Rx
2022-01-05
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: NOREPINEPHRINE, 4 mg per 250 mL, (18 mcg per mL) in 0.9% Sodium Chloride Injecti
2022-01-05
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: Sodium Bicarbonate in 5% Dextrose Injection, Rx Only, SterRx, 141 Idaho Ave., Pl
2022-01-05
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: PHENYLepherine HCL in 0.9% Sodium Chloride, 20 mg per 250 mL (80 mcg per mL), Rx
2022-01-05
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: NOREPINEPHRINE 4 mg per 250 mL (16 mcg per mL) in 5% Dextrose Injection, Rx only
2022-01-05
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: Fentanyl Citrate, in 0.9% Sodium Chloride Injection, 2.5 mg per 250 mL, (10 mcg
2022-01-05
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: EPINEPHIrine in 0.9% Sodium Chloride Injection, 8 mg per 250 mL (32 mcg per mL),
2022-01-05
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: EPINEPHrine in 0.9% Sodium Chloride Injection, 16 mg per 250 mL (64 mcg per mL),
2022-01-05
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: EPINEPHrine, 2 mg per 250 mL (8 mcg per mL) in 0.9% Sodium Chloride Injection, R
2022-01-05
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: dilTIAZem HCl in 5% Dextrose Injection, 125 mg per 125 mL, (32 mcg per mL), Rx o
2022-01-05
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: EPINEPHIrine in 0.9% Sodium Chloride Injection, 4 mg per 250 mL (16 mcg per mL),
2022-01-05
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: PHENYLephrine HCl, 50 mg per 250 mL, (200 mg per mL) in 0.9% Sodium Chloride Inj
2022-01-05
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: EPINEPHIrine in 0.9% Sodium Chloride Injection, 5 mg per 250 mL (20 mcg per mL),
2022-01-05
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: Morphine Sulfate in 0.9% Sodium Chloride Injection, 100 mg per 100 mL (1 mg per
2022-01-05
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: NOREPINEPHRINE in 5% Dextrose Injection, 8 mg per 250 mL (32 mg per mL) Injectio
2022-01-05
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: Sodium Bicarbonate in 5% Dextrose Injection, 150 mEq per 1,000 mL (12.6 mg per m
2021-09-01
Class I — Non-Sterility: firm's third party lab confirmed microbial contamination.
View Source
FDA Drug Recall: Sodium Bicarbonate in 5% Dextrose Injection, 150 mEq per 1,000 mL (12.6 mg per m
2021-09-01
Class II — Lack of Assurance of Sterility
View Source
ny_corps
1 records
NY Corp: STERRX, LLC
2013-08-15
DOMESTIC LIMITED LIABILITY COMPANY | County: Franklin | Jurisdiction: New York
View Source
Be informed when major changes happen on C.F.A.I. — new data sources, platform updates, critical enforcement alerts
No spam. Only major updates. Unsubscribe anytime.